U.S. SECURITIES AND EXCHANGE ~~COMMISSION Washington~~COMMISSIONWashington, D.C. 20549

Form 10-Q

Mark One

~~[X]~~ x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September~~March 3031, ~~2015~~2016

~~[ ]~~ ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to _____________

Commission File No. 333-194145

~~MERECOT~~ MEDRESPONSE CORP. ~~(Exact name of registrant as specified in its charter)~~

(f/k/a Merecot Corp.)
(Exact name of registrant as specified in its charter)

Nevada		68-0683374
(State of incorporation)		(IRS Employer ID Number)

~~7040 Hayvenhurst~~15462 ~~Avenue Van~~Cabrito RoadVan Nuys, CA ~~91406 818~~91406818-442-9222 (Address and telephone number of principal executive offices)

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ~~[X]~~¨ No ~~[ ]~~x

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨ ~~[X]~~ No ~~[ ]~~x

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “"large accelerated filer,”" “"accelerated filer”" and “"smaller reporting company”" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer [¨ ] Accelerated filer [¨ ] Non-accelerated filer [¨ ] Smaller reporting company ~~[X]~~x (Do not check if a smaller reporting company)

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes x ~~[X]~~ No ~~[ ]~~¨

As of ~~November~~April 128, ~~2015~~2016 there were 79,~~160~~560,000 shares of common stock, par value $0.001 per share outstanding.

MEDRESPONSE CORP.(f/k/a MERECOT CORP.)FORM 10-Q

~~FORM 10-Q~~MARCH 31, 2016

SEPTEMBER 30, 2015

INDEX

		Page No.
PART I – FINANCIAL INFORMATION
Item 1.	Financial Statements	3
Item 2.	Management’'s Discussion and Analysis of Financial Condition and Results of Operations	1013
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	1316
Item 4.	Controls and Procedures	1317
PART II – OTHER INFORMATION
Item 1.	Legal Proceedings	1419
Item 1A.	Risk Factors
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	1419
Item 3.	Defaults Upon Senior Securities	1419
Item 4.	Mine Safety Disclosures	1419
Item 5.	Other Information	1419
Item 6.	Exhibits	1520
SIGNATURES		1621

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

TABLE OF CONTENTS

Index to Financial Statements		Page
Condensed Balance Sheets as of September 30, 2015 (unaudited) and December 31, 2014		4
Balance Sheets as of March 31, 2016 (unaudited) and December 31, 2015		4
Condensed Statements of Operations for the three months and nine months ended September 30, 2015 and 2014 (unaudited)		5
Statements of Operations for the three months ended March 31, 2016 and 2015 (unaudited)		5
Condensed Statements of Cash Flows for the nine months ended September 30, 2015 and 2014 (unaudited)		6
Statements of Cash Flows for the three months ended March 31, 2016 and 2015 (unaudited)		6
Notes to Condensed Financial Statements (unaudited)		7
Notes to Financial Statements (unaudited)		7

~~MERECOT~~ MEDRESPONSE CORP.

(f/k/a Merecot Corp.)

Condensed Balance Sheets

	September 30, 2015			December 31, 2014
	March 31,			December 31,
	2016			2015
	(unaudited)
ASSETS
Current assets
Cash	$	-16		$	~~13,627~~100
Total current assets		-16			~~13,627~~100
Equipment, net		501			658
Total assets	$	16		$	100
Total assets	$	501		$	14,285
LIABILITIES AND STOCKHOLDERS' DEFICIT
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities
Advances from stockholder	$	-		$	1,001
Notes payable	$	11,500		$	1,500
Loan payable - stockholder		2,875			5,000
Accounts payable		12,332			5,449
Total current liabilities		2,875			6,001
Accounts payable to related party		100			100
Total liabilities		2,875			6,001
Other payable		-			10,000
Accrued expenses		361			21
Total current liabilities		24,293			17,070
Total liabilities		24,293			17,070
Commitments and contingencies (Note 4)
Stockholders’ equity (deficit)
Stockholders' deficit
Common stock, $0.001 par value, 75,000,000 shares authorized, 7,160,000 shares issued and outstanding, respectively		7,160			7,160
Common stock, $0.001 par value, 75,000,000 shares authorized, 9,560,000 and 9,560,000 shares issued and outstanding, respectively		9,560			9,560
Additional paid-in capital		1929,~~440~~040			1929,~~440~~040
Accumulated deficit		(2862,~~974~~877	)		(1855,~~316~~570	)
Total stockholders’ equity (deficit)		(2,374	)		8,284
Total stockholders' deficit		(24,277	)		(16,970	)
Total liabilities and stockholders’ equity (deficit)	$	501		$	14,285
Total liabilities and stockholders' deficit	$	16		$	100

See accompanying notes to unaudited financial statements.

~~MERECOT~~ MEDRESPONSE CORP.

(f/k/a Merecot Corp.)

Condensed Statements of Operations

For the Three Months Ended March 31,

(unaudited)

	For the three months ended September 30,						For the nine months ended September 30,
	2016			2015
	2015			2014			2015			2014
Revenue	$	-		$	-
Revenue	$	-		$	-		$	-		$	-
Operating expenses
Operating expenses
Professional fees		6,850			300
Professional fees		1,812			750			9,909			5,603
General and administrative		116			260
General and administrative		53			312			749			1,170
Operating loss		(6,966	)		(560	)
Net loss	$	(1,865	)	$	(1,062	)	$	(10,658	)	$	(6,773	)
Other income (expense)
Net loss per share - basic and diluted and diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)
Interest expense		(341	)		-
Weighted average number of sharesoutstanding - basic and diluted		7,160,000			6,012,144			7,160,000			5,348,152
Total other income (expense)		(341	)		-
Net loss	$	(7,307	)	$	(560	)
Net loss per share - basic and diluted and diluted	$	(0.00	)	$	(0.00	)
Weighted average number of shares outstanding - basic and diluted		9,560,000			7,160,000

See accompanying notes to unaudited financial statements.

~~MERECOT~~ MEDRESPONSE CORP.

(f/k/a Merecot Corp.)

Condensed Statements of Cash Flows

For the ~~Nine~~Three Months Ended ~~September~~March 3031,

(unaudited)

	2015			2014
	2016			2015
Cash flows from operating activities:
Net loss	$	(107,~~658~~307	)	$	(~~6,773~~560	)
Adjustments to reconcile net loss to net cash used in operations:
Depreciation expense		~~157~~-			69104
Net cash used in operating activities		(10,501	)		(6,704	)
Changes in operating assets and liabilities:
Cash flows provided by investing activities
Accounts payable		6,883			-
Acquisition of property and equipment		-			(692	)
Accrued expenses		340			-
Net cash provided by investing activities		-			(692	)
Net cash used in operating activities		(84	)		(456	)
Cash flows from financing activities:
Net increase (decrease) in cash		(84	)		(456	)
Advances from (repayments to) stockholders		(1,001	)		27
Cash at beginning of period		100			13,627
Loan payable - stockholder		5,000			-
Cash at end of period	$	16		$	13,171
Repayment to stockholder		(7,125	)		-
Common stock issued for cash		-			21,600
Net cash provided by financing activities		(3,126	)		21,627
Net decrease in cash		(13,627	)		14,231
Cash at beginning of period		13,627			7,830
Cash at end of period	$	-		$	22,061
Supplemental disclosure of cash flow information:
Cash paid for interest	$	-		$	-
Cash paid for taxes	$	-		$	-
Non-cash investing and financing activities:
Conversion of accounts payable to note payable	$	10,000		$	-

See accompanying notes to unaudited financial statements.

~~MERECOT~~ MEDRESPONSE CORP.
~~Notes to~~ (f/k/a ~~Condensed~~MERECOT ~~Financial Statements~~CORP.)
Notes to Condensed Financial Statements

~~September 30~~March 31, ~~2015~~2016

(unaudited)

NOTE 1 -– ORGANIZATION AND OPERATIONS

Organization

~~Merecot~~ Medresponse Corp. (the “"Company,”" “"we,”" “"us,”" “"our,”" or ~~“Merecot”~~"Medresponse") was incorporated in the State of Nevada on June 21, 2013, under the name of Merecot Corp. The Company ~~engages~~was originally engaged in ~~creating~~the ~~supply~~business ~~chain~~of creating Web ~~Services~~services to the ~~SPA~~Spa and Wellness industry.

On September 17, 2015, the Company experienced a change in control. Dr. Arthur Malone, Jr. acquired a controlling interest of the issued and outstanding common stock of the Company in accordance with stock purchase agreements by and between Dr. Malone and Evgenia Gonikman (the "Seller"). On the closing date, September 17, 2015, pursuant to the terms of the Stock Purchase Agreement, Dr. Malone purchased from the Seller 5,000,000 shares of the Company's outstanding restricted stock for $25,000, representing 69.8% of total shares.

On November 10, 2015, the Company experienced a change in control. Andrew Stepansky acquired a controlling interest of the issued and outstanding common stock of the Company in accordance with stock purchase agreements by and between Mr. Stepansky and Dr. Malone (the "Seller"). On the closing date, November 10, 2015, pursuant to the terms of the Stock Purchase Agreement, Mr. Stepansky purchased from the Seller 5,000,000 shares of the Company's outstanding restricted stock for $25,000, representing 69.8% of total shares.

Nature of Operations

We are currently exploring the medical industry, specifically the transportation segment in regards to ambulance services.

Basis of Presentation

The accompanying unaudited financial statements of ~~Merecot~~Medresponse have been prepared in accordance with generally accepted accounting principles ("GAAP") for interim financial information and the instructions to Form 10-Q and Article 8 of Regulation S-X. The results of operations for the interim period ended ~~September~~March 3031, ~~2015~~2016 shown in this report are not necessarily indicative of results to be expected for the full fiscal year ending June 30, 2016. In the opinion of the Company’'s management, the information contained herein reflects all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation of the Company’'s results of operations, financial position and cash flows. The unaudited interim financial statements should be read in conjunction with the audited financial statements in the Company’'s Form 10-K for the year ended December 31, ~~2014~~2015 filed on ~~June~~March 830, ~~2015~~ 2016 and Management’'s Discussion and Analysis of Financial Condition and Results of Operations.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.

Property, Equipment and Depreciation

Property and equipment is recorded at cost. Depreciation is computed using the straight-line method based on the estimated useful lives of the related assets of three years for computer equipment, five years for office furniture and fixtures, and the lesser of the lease term or the useful life of the leased equipment. Leasehold improvements, if any, would be amortized over the lesser of the lease term or the useful life of the improvements. Expenditures for maintenance and repairs along with fixed assets below our capitalization threshold are expensed as incurred.

Revenue Recognition

The Company recognizes revenue for our services in accordance with ASC 605-10, "Revenue Recognition in Financial Statements." Under these guidelines, revenue is recognized on transactions when all of the following exist: persuasive evidence of an arrangement did exist, delivery of service has occurred, the sales price to the buyer is fixed or determinable and collectability is reasonably assured. The Company's business plan has, for the future, one primary revenue stream as follows:

Ambulance services.

Stock-Based Compensation

The Company accounts for stock-based instruments issued to employees in accordance with ASC Topic 718. ASC Topic 718 requires companies to recognize in the statement of operations the grant-date fair value of stock options and other equity based compensation issued to employees. The value of the portion of an award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line attribution method. The Company accounts for non-employee share-based awards in accordance with the measurement and recognition provisions ASC Topic 505-50. The Company estimates the fair value of stock options at the grant date by using the Black-Scholes option-pricing model.

Income Taxes

Beginning September 1, 2009, the Company adopted the provisions of ASC 740-10, "Accounting for Uncertain Income Tax Positions." When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all highly certain of being upheld upon examination. As such, the Company has not recorded a liability for unrecognized tax benefits. As of March 31. 2016, tax years 2015 and 2014 remain open for IRS audit. The Company has received no notice of audit from the IRS for any of the open tax years.

Effective September 1, 2009, the Company adopted ASC 740-10, "Definition of Settlement in FASB Interpretation No. 48," ("ASC 740-10"), which was issued on May 2, 2007. ASC 740-10 amends FIN 48 to provide guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits. The term "effectively settled" replaces the term "ultimately settled" when used to describe recognition, and the terms "settlement" or "settled" replace the terms "ultimate settlement" or "ultimately settled" when used to describe measurement of a tax position under ASC 740-10. ASC 740-10 clarifies that a tax position can be effectively settled upon the completion of an examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. The adoption of ASC 740-10 did not have an impact on the accompanying financial statements.

Fair Value of Financial Instruments

The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“"Paragraph 820-10-35-37”") to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in generally accepted accounting principles (GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:

Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.

Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.

Level 3: Pricing inputs that are generally observable inputs and not corroborated by market data.

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

The carrying amounts of the Company’'s financial assets and liabilities, such as cash and accrued expenses approximate their fair values because of the short maturity of these instruments.

Transactions involving related parties cannot be presumed to be carried out on an arm’'s-length basis, as the requisite conditions of competitive, free-market dealings may not exist. Representations about transactions with related parties, if made, shall not imply that the related party transactions were consummated on terms equivalent to those that prevail in arm’'s-length transactions unless such representations can be substantiated.

Going Concern

The accompanying unaudited financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company sustained net losses of $107,~~658~~307 and used cash in operating activities of $~~10,501~~84 for the ~~nine~~three months ended ~~September~~March 3031, ~~2015~~2016. The Company had working capital deficit, stockholders’' deficiency and accumulated deficit of $224,~~875~~277, $224,~~374~~277 and $2862,~~974~~877, respectively, at ~~September~~March 3031, ~~2015~~2016. These factors raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time. The Company’'s continuation as a going concern is dependent upon its ability to generate revenues and its ability to continue receiving investment capital and loans from third parties to sustain its current level of operations. The Company is in the process of securing working capital from investors for common stock, convertible notes payable, and/or strategic partnerships. No assurance can be given that the Company will be successful in these efforts.

~~MERECOT CORP~~The accompanying consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplate continuation of the Company as a going concern and the realization of assets and satisfaction of liabilities in the normal course of business. The ability of the Company to continue its operations is dependent on the execution of management's plans, which include the raising of capital through the debt and/or equity markets, until such time that funds provided by operations are sufficient to fund working capital requirements. If the Company were not to continue as a going concern, it would likely not be able to realize its assets at values comparable to the carrying value or the fair value estimates reflected in the balances set out in the preparation of the consolidated financial statements.

~~Notes~~ There can be no assurances that the Company will be successful in generating additional cash from the equity/debt markets or other sources to ~~Condensed~~be ~~Financial~~used ~~Statements~~for operations. The consolidated financial statements do not include any adjustments relating to the recoverability of assets and classification of assets and liabilities that might be necessary. Based on the Company's current resources, the Company will not be able to continue to operate without additional immediate funding. Should the Company not be successful in obtaining the necessary financing to fund its operations, the Company would need to curtail certain or all operational activities and/or contemplate the sale of its assets, if necessary.

September 30, 2015

(unaudited)

The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the amortization period for intangible assets, valuation and impairment valuation of intangible assets, depreciable lives of the web site and property and equipment, valuation of warrants and beneficial conversion feature debt discounts, valuation of derivatives, valuation of share-based payments and the valuation allowance on deferred tax assets.

Reclassifications

Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation. These reclassifications had no effect on reported losses, total assets, or stockholders’' equity as previously reported.

Net Earnings (Loss) Per Share

In accordance with ASC 260-10, “"Earnings Per Share,”" basic net earnings (loss) per common share is computed by dividing the net earnings (loss) for the period by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share are computed using the weighted average number of common and dilutive common stock equivalent shares outstanding during the period.

Segment Information

In accordance with the provisions of ASC 280-10, “Disclosures about Segments of an Enterprise and Related Information,” the Company is required to report financial and descriptive information about its reportable operating segments. The Company does not have any operating segments as of September 30, 2015 and 2014.

Effect of Recent Accounting Pronouncements

The Company reviews new accounting pronouncements as issued. No new pronouncements had any material effect on these unaudited financial statements. The accounting pronouncements issued subsequent to the date of these unaudited financial statements that were considered significant by management were evaluated for the potential effect on these unaudited financial statements. Management does not believe any of the subsequent pronouncements will have a material effect on these unaudited financial statements as presented and does not anticipate the need for any future restatement of these unaudited financial statements because of the retro-active application of any accounting pronouncements issued subsequent to ~~September~~March 3031, ~~2015~~2016 through the date these unaudited financial statements were issued.

NOTE 2 – STOCKHOLDERS’ DEFICIT

Shares Authorized

Upon formation the total number of shares of all classes of stock which the Company is authorized to issue is 75,000,000 shares of which 75,000,000 shares shall be Common Stock, par value $0.001 per share.

Common Stock

On December 3, 2013 the Company sold 5,000,000 shares of common stock to the founder of the Company at $0.001 per share, or $5,000 in cash. Between June 18, 2014 and September 26, 2014 the Company sold 2,160,000 shares of common stock to 27 stockholders at $0.01 per share, or $21,600 in aggregate for cash.

NOTE 3 - RELATED PARTIES

From time to time, the former Chairman, CEO and significant stockholder of the Company, Dr. Art Malone, advanced funds to the Company for working capital purpose. Those advances are unsecured, non-interest bearing and due on demand. As of September 30, 2015 and December 31, 2014, $0 and $1,001, respectively, was due to Dr. Malone.

MERECOT CORP.

Notes to Condensed Financial Statements

September 30, 2015

(unaudited)

On July 5, 2013, the Company executed a loan agreement in the amount of $5,000 payable to Dr. Malone. A second borrowing installment of Dr. Malone’s loan in the amount of $5,000 was received on April 4, 2015. The balance due to Dr. Malone as of September 30, 2015 is $2,875. The loan is unsecured, non-interest bearing with no fixed term of repayment.

On November 10, 2015, Dr. Malone sold 5,000,000 shares of common stock to the Company, to Andrew Stepansky, for $25,000, constituting a change of control of the Company as Mr. Stepansky now owns 52.3% of the voting securities of the Company.

NOTE 4 - COMMITMENT AND CONTINGENCIES

The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

NOTE 5 - SUBSEQUENT EVENTS

The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements were issued. Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

SPECIAL NOTE CONCERNING FORWARD-LOOKING STATEMENTS

We believe that it is important to communicate our future expectations to our security holders and to the public. This report, therefore, contains statements about future events and expectations which are “forward-looking statements” within the meaning of Sections 27A of the Securities Act of 1933 and 21E of the Securities Exchange Act of 1934, including the statements about our plans, objectives, expectations and prospects under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” You can expect to identify these statements by forward-looking words such as “may,” “might,” “could,” “would,” “will,” “anticipate,” “believe,” “plan,” “estimate,” “project,” “expect,” “intend,” “seek” and other similar expressions. Any statement contained in this report that is not a statement of historical fact may be deemed to be a forward-looking statement. Although we believe that the plans, objectives, expectations and prospects reflected in or suggested by our forward-looking statements are reasonable, those statements involve risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements, and we can give no assurance that our plans, objectives, expectations and prospects will be achieved.

Important factors that might cause our actual results to differ materially from the results contemplated by the forward-looking statements are contained in the “Risk Factors” section of and elsewhere in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014 and in our subsequent filings with the Securities and Exchange Commission. The following discussion of our results of operations should be read together with our financial statements and related notes included elsewhere in this report.

Company Overview

We are a development stage company with nominal revenue earned to date and minimum operations and assets. Since our incorporation, our management has determined our business plan to create automated supply chain Web Services to the SPA and Wellness industry, identified our target market and obtained initial funding of $10,000 from our director. We will require additional funding in order to pursue our business objectives and there is no guarantee that we will be successful in this regard.

Our plan of operation is to design, develop, and run Web Services that will connect manufacturers and distributors of the SPA products and equipment with individual SPA and Wellness outlets. The Web Services will perform multiple business functions including automated inventory control, delivery scheduling, introduction of the new products and equipment.

Our principal executive office is located at 7040 Hayvenhurst Avenue, Van Nuys, California 91406. Our telephone number is (818) 442-9222, and our registered agent for service of process is the Incorp Services, Inc., located at 2360 Corporate Circle, Suite 400, Henderson, Nevada, 89074-7722. We were incorporated in the State of Nevada on June 21, 2013. Our fiscal year end is December 31.

Product

Description of Product Services

The services offered by Merecot Corp. are based on a distributed Cloud location with well-defined interfaces. There are 2 types of interfaces. One interface is for suppliers and manufacturers of SPA products and equipment and another is for consumers (individual SPA and Wellness locations). These services will fulfill the following functionality:

1. Provide consumers with detailed information about products available in their geographical area

2. Complete single and/or recurring purchases

3. Setup delivery schedule

4. Preset minimum inventory levels that will trigger next delivery

5. Provide facility to return damaged or unwanted items

6. Limit access to the services only to authorized personnel

There will be a grace period for the consumers who want to try services and see how they can improve the productivity and effectiveness of their company.

Target Market and Clients/Potential Clients

Our target clients are divided in two categories:

Category 1: the individual SPA and Wellness locations, small and medium size franchises.

Category 2: SPA and Wellness product and equipment manufacturers and distributors

Geographically both categories could be located anywhere in the world although at the initial stage of our development we’ll target the North American markets.

~~Source of~~NOTE ~~Revenue~~2 – CONVERTIBLE NOTES PAYABLE, NET OF DISCOUNTS

~~The key~~On ~~factor~~November in20, ~~estimating~~2015, ~~pricing~~the isCompany toexecuted ~~attract~~a ~~more~~convertible ~~SPA~~promissory ~~and~~note ~~Wellness~~with ~~locations~~Embles ~~because~~Financial, ofInc. ~~that~~("Embles weFinancial") ~~will~~for ~~charge~~$1,500, ~~them~~in exchange for Embles Financial paying a ~~very~~vendor ~~modest fee~~of ~~just~~the toCompany ~~cover~~directly for a liability of the ~~expenses~~Company. toThe ~~support~~note ~~them~~bears ininterest ~~using~~at ~~our~~the ~~services~~rate of 12% per annum, which accrues monthly. ~~Moreover~~As of March 31, 2016, the ~~first~~accrued 6interest ~~months~~was ~~will~~$66. beThe ~~free~~note somatures ~~they~~on ~~can~~November ~~appreciate~~ 19, 2016. The note has a conversion feature of $0.04 per share. A beneficial conversion feature was not recorded as the ~~convenience~~Company has yet to publicly trade its common stock and ~~benefits~~value ofwas ~~our~~deemed ~~services~~nominal.

~~Customer’s fee~~On ~~(Individual~~January ~~SPA~~2, 2016, the Company executed a convertible promissory note with Embles Financial for $10,000, in exchange for accounts payable to Embles Financial. The note bears interest at the rate of 12% per annum, which accrues monthly. As of January 31, 2016, the accrued interest was $296. The note matures on January 2, 2017. The note has a conversion feature of $0.04 per share. A beneficial conversion feature was not recorded as the Company has yet to publicly trade its common stock and ~~Wellness~~value ~~locations)~~was deemed nominal.

~~The first~~NOTE 63 ~~months~~– ~~free~~COMMITMENTS ~~after~~AND ~~the first 6 months fixed monthly fee of $39.99 USD~~CONTINGENCIES

~~The main~~Legal source of our revenue will be commissions paid by suppliers and manufacturers. This is the flat fixed fee and the percentage of the sold products through our services. To attract suppliers and encourage them to build up the sales network we propose to charge sales commissions based on the volume of sold products. That means the more volume of the sold product using our services the less percentage the Supplier will be charged.Matters

Supplier’s fees
Fixed monthly fee		Percentage of the total amount of sold products
$99.99 USD		% based on the volume of sales

From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. As of April 8, 2016, there were no pending or threatened lawsuits, except as follows:

~~Marketing Strategy~~The Company has been threatened with legal action with a vendor for $2,000. The Company has not completed the transaction as it disputes the quality of services provided by the vendor and cancelled the contract with the vendor. The Company will contest the charge accordingly. Management has determined that the eventual outcome will not have significant effect on the Company's financial statements.

~~The marketing~~NOTE ~~approach~~4 is– toRELATED offer our services for free for a trial period of 6 months to the SPA locations and 3 months to the suppliers and manufacturers. Suppliers and manufacturers will be contacted directly by our sales representatives.PARTIES

~~Individual SPA~~Andrew ~~locations~~Stepansky, ~~will~~an ~~receive~~officer ~~published information~~ and ~~free~~director ~~offers~~of ~~via~~the ~~regular~~Company, ~~mail.~~has ~~Extended~~payables ~~information~~ and ~~offers~~accruals ~~will~~due beto ~~also available~~him onof ~~our~~$100 ~~website. We will use Google~~ and ~~YouTube~~$100 ~~web~~as ~~advertisement~~of ~~campaign~~March ~~that~~31, ~~targets~~2016 ~~both~~and ~~categories~~December of31, ~~our customers~~2015.

~~Competition~~ Evgenia Gonikman, the former officer and ~~Competitive~~director ~~Strategy~~of the Company, had a loan payable due to her of $5,000 as of December 31, 2014. The loan was unsecured, non-interest bearing and due on demand. As part of the change of control, the balance of $10,000 due to Ms. Gonikman was assigned to a third party (see Note 8). The Company's bank account, which had $6,200, was withdrawn by Ms. Gonikman prior to the change in control, thereby resulting in a loss on the settlement of debt of $6,200.

~~Currently there~~On ~~are~~November no9, ~~direct~~2015, ~~competitors~~prior ~~that~~to ~~are~~the ~~offering~~change of control, the ~~same~~Company ~~services~~issued 2,000,000 shares of common stock to Turo LLC, a company controlled by Dr. ~~There~~Malone, ~~are~~the ~~numbers~~CEO and Director of ~~potential~~the ~~competitors~~Company at that ~~provide~~time. ~~some elements~~The ofstock ~~what~~was ~~Merecot~~issued ~~Corp.~~for ~~will~~services ~~offer~~rendered, tovalued ~~their~~at ~~customers~~$10,000, asor ~~integrated~~$0.005 ~~package~~per share. See Note 5.

~~We can~~On ~~categorize~~November ~~our~~9, ~~competitors~~2015, ~~into~~the ~~two~~Company ~~groups:~~issued 200,000 shares of common stock to Emaln, LLC, a company controlled by a person related to Dr. Malone. The stock was issued for services rendered, valued at $1,000, or $0.005 per share. See Note 5.

1. The companies that sell SPA products and equipment.

2. The companies that sell Vendor Management, Supplier Management, and Inventory Management Systems.

We cannot guarantee that we will be able to attract enough customers and that we will be able to compete effectively because we have not yet begun operations. We do not have a competitive position relative to these other companies. Once we launch operations, we hope to compete on the basis of price, quality and the novelty of our services. We intend to offer new services to the SPA and Wellness industry. We intend to capitalize on our president’s knowledge of SPA business. We intend to compete on price for our Web Services. While our profit margins will be smaller on our SPA services, we intend to compensate for this by having larger margins on services offered to manufacturers and distributors of the SPA products and equipment.

Our operations and our ability to generate revenues will be harmed if we are unable to establish a reputation as a provider of quality services.

Currently, our competitive position within the industry is negligible in light of the fact that we have not started our operations.

RESULTS OF OPERATION

Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operation. We expect we will require additional capital to meet our long term operating requirements. We expect to raise additional capital through, among other things, the sale of equity or debt securities.

~~For the~~NOTE ~~Three~~5 ~~Months~~– ~~Ended~~STOCKHOLDER'S ~~September 30, 2015 and 2014~~EQUITY

~~We have~~Upon noformation ~~revenue~~the ~~from~~total ~~inception~~number of shares of all classes of stock which the Company is authorized to ~~date~~issue is 75,000,000 shares of which 75,000,000 shares shall be common stock, par value $0.001 per share.

~~For the~~Common three months ended September 30, 2015, our total operating expenses were $1,865 compared to $1,062 for the three months ended September 30, 2014, resulting in an increase of $803. As a result, net loss was $1,865 for the three months ended September 30, 2015 compared to net loss of $1,062 for the three months ended September 30, 2014.Stock

~~For the~~On ~~Nine~~June ~~Months~~21, ~~Ended~~2013, ~~September~~upon 30formation, ~~2015~~the ~~and~~Company ~~2014~~sold 5,000,000 shares of common stock to the founder of the Company at $0.001 per share, or $5,000.

~~We have~~Between noJune ~~revenue~~18, ~~from~~2014 ~~inception~~and September 26, 2014 the Company sold 2,160,000 shares of common stock to ~~date~~27 stockholders at $0.01 per share, or $21,600 in aggregate for cash.

~~For the~~On ~~nine~~November ~~months ended September 30~~9, 2015, ~~our~~the ~~total~~Company ~~operating~~issued ~~expenses~~2,000,000 ~~were~~shares ~~$10,658~~of ~~compared~~common stock to $6Turo LLC,~~773~~ ~~for~~a ~~the~~company ~~nine~~controlled ~~months~~by ~~ended September~~Dr. 30Malone, ~~2014,~~the ~~resulting~~CEO inand anDirector ~~increase~~ of ~~$3,885.~~the AsCompany aat ~~result,~~that ~~net~~time. ~~loss~~The stock was ~~$10,658~~issued for ~~the~~services ~~nine~~rendered, ~~months~~valued ~~ended~~at ~~September 30~~$10,000, ~~2015~~or ~~compared~~$0.005 toper ~~net~~share, ~~loss~~as ofdetermined ~~$6,773~~by ~~for~~ the ~~nine~~Board ~~months~~of ~~ended~~Directors ~~September~~of ~~30,~~the ~~2014~~Company. See Note 4.

~~Liquidity and~~On ~~Capital~~November ~~Resources~~9, 2015, the Company issued 200,000 shares of common stock to Looney Enterprises, a company controlled by Dr. Malone. The stock was issued for services rendered, valued at $1,000, or $0.005 per share, which was based on the value established on other issuances on this day.

~~As of~~On ~~September~~November 309, 2015, the Company ~~had~~issued $0200,000 inshares ~~cash.~~of Wecommon dostock ~~not~~to ~~have~~Emaln, ~~sufficient~~LLC, ~~resources~~a tocompany ~~effectuate~~controlled ~~our~~by ~~business.~~a Weperson ~~expect~~related to ~~incur~~ aDr. ~~minimum~~Malone. ofThe ~~$50,000~~stock inwas ~~expenses~~issued ~~during~~for ~~the~~services ~~next~~rendered, ~~twelve~~valued ~~months~~at of$1,000, ~~operations~~or $0.005 Weper ~~estimate~~share, ~~that~~which ~~these~~was ~~expenses~~based ~~will~~on bethe ~~comprised primarily~~value ofestablished ~~general~~on ~~expenses~~other ~~including~~issuances ~~overhead,~~on ~~legal~~this ~~and~~day. ~~accounting~~See ~~fees~~Note 4.

~~CASH FLOWS~~NOTE ~~FROM~~6 ~~OPERATING~~– ~~ACTIVITIES~~SUBSEQUENT EVENTS

~~We used~~The ~~cash~~Company inhas ~~operations~~evaluated ofall ~~$10,501~~events ~~for~~that ~~the~~occur ~~nine~~after ~~months~~the ~~ended~~balance ~~September~~sheet ~~30,~~date ~~2015~~through ~~compared~~the todate ~~cash~~when ~~used~~the infinancial ~~operations~~statements ofwere ~~$6,704 for~~issued ~~the~~to ~~nine~~determine ~~months~~if ~~ended~~they ~~September~~must ~~30,~~be ~~2014~~reported. The ~~negative~~Management ~~cash~~of ~~flow from operating activities for~~ the ~~nine~~Company ~~months~~determined ~~ended~~that ~~September 30,~~there ~~2015~~were isno ~~primarily~~reportable tosubsequent ~~the Company’~~event(s) ~~net~~to ~~loss~~be ~~from operations of $10~~disclosed,~~658.~~ ~~Cash~~other ~~used~~than inas ~~operations for the nine months ended September 30, 2014 is primarily attributable to the Company’s net loss of $6,773~~below.

~~We used~~Embles ~~cash~~Financial has paid certain financial obligations of the Company subsequent to March 31, 2016 in ~~investing~~the ~~activities~~amount of $016,332. The Company and ~~$692~~Embles ~~for~~has ~~the~~not ~~nine~~formalized ~~months~~any ~~ended~~repayment ~~September~~documentation ~~30,~~as ~~2015~~of ~~and~~the ~~2014,~~date ~~respectively~~of this filing.

We had net cash provided (used in) by financing activities of $(3,126) and $21,627 for the nine months ended September 30, 2015 and 2014, respectively, with the primarily decrease in the current year due to a loan payable to a stockholder for $5,000 offset by repayment of the loan in the amount of $7,125.
We will have to raise funds to pay for our expenses. We may have to borrow money from shareholders or issue debt or equity or enter into a strategic arrangement with a third party. There can be no assurance that additional capital will be available to us. We currently have no arrangements or understandings with any person to obtain funds through bank loans, lines of credit or any other sources. Since we have no such arrangements or plans currently in effect, our inability to raise funds for our operations will have a severe negative impact on our ability to remain a viable company.
Plan of Operation and Funding
We expect that working capital requirements will continue to be funded through a combination of our existing funds and further issuances of securities. Our working capital requirements are expected to increase in line with the growth of our business.
Existing working capital, further advances and debt instruments, and anticipated cash flow are expected to be adequate to fund our operations over the next three months. We have no lines of credit or other bank financing arrangements. Generally, we have financed operations to date through the proceeds of the private placement of equity and debt instruments. In connection with our business plan, management anticipates additional increases in operating expenses and capital expenditures relating to: (i) acquisition of inventory; (ii) developmental expenses associated with a start-up business; and (iii) marketing expenses. We intend to finance these expenses with further issuances of securities, and debt issuances. Thereafter, we expect we will need to raise additional capital and generate revenues to meet long-term operating requirements. Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders. Further, such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict our business operations. We will have to raise additional funds in the next twelve months in order to sustain and expand our operations. We currently do not have a specific plan of how we will obtain such funding; however, we anticipate that additional funding will be in the form of equity financing from the sale of our common stock. We have and will continue to seek to obtain short-term loans from our directors, although no future arrangement for additional loans has been made. We do not have any agreements with our directors concerning these loans. We do not have any arrangements in place for any future equity financing.

12

~~Going Concern~~Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

~~The accompanying~~SPECIAL ~~unaudited~~NOTE ~~financial~~CONCERNING ~~statements~~FORWARD-LOOKING have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company had revenue of $0 and net losses of $10,658 for the nine months ended September 30, 2015 compared to revenue of $0 and net losses of $6,773 for the nine months ended September 30, 2014. The Company had working capital deficiency, stockholders’ deficit, and accumulated deficit of $2,875, $2,374 and $28,974, respectively, at September 30, 2015, and used cash in operations of $8,689 for the nine months ended September 30, 2015. These factors raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time. The Company is highly dependent on its ability to continue to obtain investment capital from future funding opportunities to fund the current and planned operating levels. The unaudited financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s continuation as a going concern is dependent upon its ability to bring in income generating activities and its ability to continue receiving investment capital from future funding opportunities. No assurance can be given that the Company will be successful in these efforts.STATEMENTS

~~Off Balance~~We ~~Sheet~~believe ~~Arrangements~~that it is important to communicate our future expectations to our security holders and to the public. This report, therefore, contains statements about future events and expectations which are "forward-looking statements" within the meaning of Sections 27A of the Securities Act of 1933 and 21E of the Securities Exchange Act of 1934, including the statements about our plans, objectives, expectations and prospects under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations." You can expect to identify these statements by forward-looking words such as "may," "might," "could," "would," "will," "anticipate," "believe," "plan," "estimate," "project," "expect," "intend," "seek" and other similar expressions. Any statement contained in this report that is not a statement of historical fact may be deemed to be a forward-looking statement. Although we believe that the plans, objectives, expectations and prospects reflected in or suggested by our forward-looking statements are reasonable, those statements involve risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements, and we can give no assurance that our plans, objectives, expectations and prospects will be achieved.

~~We currently~~Important ~~have~~factors nothat ~~off-balance~~might ~~sheet~~cause ~~arrangements~~our ~~that~~actual ~~have~~results orto differ materially from the results contemplated by the forward-looking statements are ~~reasonably~~contained ~~likely~~in tothe ~~have~~"Risk aFactors" ~~current~~section orof ~~future~~and ~~material~~elsewhere ~~effect on~~in our ~~financial~~Annual ~~condition~~Report on Form 10-K for the fiscal year ended December 31, ~~changes~~2015 and in ~~financial~~our ~~condition,~~subsequent ~~revenues~~filings orwith ~~expenses,~~the Securities and Exchange Commission. The following discussion of our results of operations, ~~liquidity,~~should ~~capital~~be ~~expenditures or~~read ~~capital~~together ~~resources~~with our financial statements and related notes included elsewhere in this report.

~~Critical Accounting~~Company ~~Policies~~Overview

The ~~preparation~~ ofCompany ~~financial~~was ~~statements in conformity with accounting principles generally accepted in the United States of America requires us to make~~ a ~~number~~startup ofcompany ~~estimates and assumptions~~ that ~~affect~~was ~~the~~incorporated ~~reported~~in ~~amounts~~Nevada ofunder ~~assets and liabilities and disclosure of contingent assets and liabilities at~~ the ~~date~~name ofMerecot ~~the financial statements~~Corp. ~~Such estimates and assumptions affect the reported amounts of revenues and expenses during the reporting period. We base our estimates~~ on ~~historical~~June ~~experiences~~13, ~~and on various other assumptions that we believe to be reasonable under the circumstances~~2014. Actual results may differ materially from these estimates under different assumptions and conditions. We continue to monitor significant estimates made during the preparation of our financial statements. On anDecember ~~ongoing~~3, ~~basis~~2015, ~~we evaluate estimates and assumptions based upon historical experience and various other factors and circumstances. We believe our estimates and assumptions are reasonable in~~ the ~~circumstances;~~Company ~~however,~~changed ~~actual~~its ~~results~~name ~~may~~to ~~differ from~~Medresponse ~~these estimates under different future conditions~~Corp.

~~See Item~~On 7September 17, ~~“Management’s~~2015, ~~Discussion~~the ~~and~~Company ~~Analysis~~experienced ofa ~~Financial~~change ~~Condition~~in ~~and~~control. ~~Results~~Dr. Arthur Malone, Jr. acquired a controlling interest of ~~Operations”~~the issued and ~~Note~~outstanding ~~2, “Summary~~common stock of ~~Significant~~the ~~Accounting~~Company ~~Policies”~~ in ~~our~~accordance ~~audited~~with ~~financial~~stock ~~statements~~purchase ~~for~~agreements by and between Dr. Malone and Evgenia Gonikman (the ~~year~~"Seller"). ~~ended~~On ~~December~~the ~~31,~~closing ~~2014~~date, ~~included~~ inSeptember ~~our~~17, ~~Annual~~2015, ~~Report~~pursuant onto ~~Form~~the ~~10-K~~terms asof ~~filed~~the onStock ~~June~~Purchase 8Agreement, ~~2015,~~Dr. ~~for~~Malone apurchased ~~discussion~~from the Seller 5,000,000 shares of ~~our~~the ~~critical~~Company's ~~accounting~~outstanding ~~policies~~restricted ~~and estimates~~stock for $25,000, representing 69.8% of total shares outstanding.

~~Item 3~~On November 10, 2015, the Company experience a change in control. ~~Quantitative~~Andrew Stepansky acquired a controlling interest of the issued and ~~Qualitative~~outstanding ~~Disclosures~~common ~~About~~stock ~~Market~~of ~~Risk~~the Company in accordance with stock purchase agreements by and between Mr. Stepansky and Dr. Malone (the "Seller"). On the closing date, November 10, 2015, pursuant to the terms of the Stock Purchase Agreement, Mr. Stepansky purchased from the Seller 5,000,000 shares of the Company's outstanding restricted stock for $25,000, representing 69.8% of total shares outstanding.

~~A smaller~~Prior ~~reporting~~to ~~company~~the two change of control transactions, aswe ~~defined~~were bya ~~Item~~startup 10company that originally intended to engage in the business of ~~Regulation~~creating ~~S-K,~~an isautomated ~~not~~supply ~~required~~chain toWeb ~~provide~~services to the ~~information~~Spa ~~required~~and byWellness ~~this item~~industry.

~~Item 4.~~The ~~Controls~~Company's business plan is to engage in medical related activities, specifically transportation services related to the medical industry and/or ~~Procedures~~management services related to medical transportation services.

~~Evaluation of Disclosure Controls and Procedures~~13

~~The Securities~~We ~~and~~have ~~Exchange~~had ~~Commission~~no ~~defines~~operations ~~the term “disclosure controls~~ and ~~procedures”~~have tobeen ~~mean~~issued a ~~company’s controls~~"going ~~and~~concern" ~~other~~opinion ~~procedures~~by ofour ~~an issuer that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded~~auditor, ~~processed,~~based ~~summarized~~upon ~~and~~our ~~reported,~~reliance ~~within~~on the ~~time~~ ~~periods~~sale specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Securities Exchange Act of ~~1934~~our iscommon ~~accumulated~~stock ~~and communicated to the issuer’s management, including its chief executive and chief financial officers, or persons performing similar functions,~~ as appropriate to allow timely decisions regarding required disclosure. The Company maintains such a system of controls and procedures in an effort to ensure that all information which it is required to disclose in the ~~reports~~sole itsource ~~files under the Securities Exchange Act~~ of ~~1934~~funds isfor ~~recorded, processed,~~our ~~summarized~~future and reported within the time periods specified under the SEC’s rules and forms and that information required to be disclosed is accumulated and communicated to the chief executive and interim chief financial officer to allow timely decisions regarding disclosureoperations.

~~As of~~Our ~~the~~principal ~~end~~executive ofoffice ~~the~~is ~~period~~located ~~covered~~at by15462 ~~this~~Cabrito ~~report~~Road, weVan ~~carried~~Nuys, ~~out~~California an91406. ~~evaluation,~~Our ~~under~~telephone ~~the~~number ~~supervision~~is ~~and~~(818) ~~with~~442-9222, ~~the~~and ~~participation of~~ our ~~Chief~~registered ~~Executive~~agent ~~Officer~~for ~~and~~service ~~Chief Financial Officer,~~ of ~~the~~process ~~effectiveness~~is of the ~~design~~Incorp ~~and~~Services, ~~operation~~Inc., oflocated ~~our~~at ~~disclosure controls~~2360 ~~and~~Corporate ~~procedures.~~Circle, ~~Based~~Suite on400, ~~this~~Henderson, ~~evaluation~~Nevada, ~~the~~89074-7722. ~~Chief~~We ~~Executive~~were ~~Officer~~incorporated ~~and~~in ~~Chief Financial Officer have concluded that~~ the ~~Company’s~~State ~~disclosure~~of ~~controls~~Nevada ~~and~~on ~~procedures~~June ~~are~~21, ~~not effective as of such date~~2013. ~~The~~Our ~~Chief~~fiscal ~~Executive~~year ~~Officer~~end ~~and~~is ~~Chief Financial~~December ~~Officer have determined that the Company continues to have the following deficiencies which represent a material weakness:~~31.

1.RESULTS ~~The~~OF Company intends to appoint additional independent directors; 2. Lack of in-house personnel with the technical knowledge to identify and address some of the reporting issues surrounding certain complex or non-routine transactions. With material, complex and non-routine transactions, management has and will continue to seek guidance from third-party experts and/or consultants to gain a thorough understanding of these transactions; 3. Insufficient personnel resources within the accounting function to segregate the duties over financial transaction processing and reporting; 4. Insufficient written policies and procedures over accounting transaction processing and period end financial disclosure and reporting processes.OPERATION

13Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operation. We expect we will require additional capital to meet our long term operating requirements. We expect to raise additional capital through, among other things, the sale of equity or debt securities.

~~To remediate~~For ~~our~~the ~~internal~~Three ~~control~~Months ~~weaknesses,~~Ended ~~management~~March ~~intends~~31, to2016 ~~implement~~and ~~the following measures:~~2015

● The Company will add sufficient number of independent directors to the board and appoint additional member(s) to the Audit Committee. ● The Company will add sufficient accounting personnel to properly segregate duties and to effect a timely, accurate preparation of the financial statements. ● The Company will hire staff technically proficient at applying U.S. GAAP to financial transactions and reporting. ● Upon the hiring of additional accounting personnel, the Company will develop and maintain adequate written accounting policies and procedures.Revenue

~~The additional~~For ~~hiring~~the isthree ~~contingent~~months ~~upon~~ended ~~The~~March ~~Company’s~~31, ~~efforts~~2016, toour ~~obtain~~revenue ~~additional~~was ~~funding~~$0, ~~through~~compared ~~equity~~to or$0 ~~debt~~for ~~and~~ the ~~results of~~same ~~its~~period ~~operations. Management expects to secure funds~~ in ~~the coming fiscal year but provides no assurances that it will be able to do so~~2015.

~~Changes in~~Operating ~~Internal Control Over Financial Reporting~~Expenses

~~Except as~~For ~~set~~the ~~forth~~three ~~above~~months ended March 31, ~~due~~2016, operating expenses were $6,966 compared to $560 for the ~~new~~same ~~business~~period ~~plan,~~in we2015. ~~are~~The increase was primarily due to increases in ~~the~~professional ~~process~~fees, of$6,850 ~~finalizing~~compared ~~our~~to ~~controls~~$300 ~~over~~for ~~the~~2016 ~~new~~and ~~business~~2015, ~~process~~respectively.

~~Limitations on~~Net ~~the Effectiveness of Controls~~Loss

~~The Company’s~~We ~~management,~~generated ~~including~~net ~~the~~losses CEO and CFO, does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all error and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Further, the design of ~~the control system must reflect that there are resource constraints and that the benefits must be considered relative to their costs. Because of the inherent limitations in all control systems~~$7,307 nofor ~~evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within~~ the ~~company~~three ~~have~~months ~~been~~ended ~~detected.~~March These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons31, ~~by collusion of two or more people~~2016, orcompared byto ~~management override~~$560 offor ~~controls. The design of any system of controls is based in part on certain assumptions about~~ the ~~likelihood~~same ofperiod ~~future events, and there can be no assurance that any design will succeed~~ in ~~achieving its stated goals under all potential future conditions~~2015. ~~Projections~~ of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

~~PART II.~~Liquidity ~~OTHER~~and ~~INFORMATION~~Capital Resources

~~Item 1~~As of March 31, 2016, the Company had $16 in cash. ~~Legal~~We ~~Proceedings~~do not have sufficient resources to effectuate our business. We expect to incur a minimum of $50,000 in expenses during the next twelve months of operations. We estimate that these expenses will be comprised primarily of general expenses including overhead, legal and accounting fees.

Management is not aware of any legal proceedings contemplated by any governmental authority or any other party involving us or our properties. As of the date of this Quarterly Report, no director, officer or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. Management is not aware of any other legal proceedings pending or that have been threatened against us or our properties.14

~~Item 2.~~CASH ~~Unregistered~~FLOWS ~~Sales~~FROM ofOPERATING ~~Equity Securities and Use of Proceeds~~ACTIVITIES

We ~~did~~ ~~not~~used ~~issue~~cash ~~unregistered~~in ~~securities~~operations ~~during~~of $84 for the ~~quarter~~three ~~ending~~months ~~September~~ended 30March 31, 2016 compared to cash used in operations of $456 for the three months ended March 31, 2015.

~~Item 3.~~We ~~Defaults~~used ~~Upon~~cash ~~Senior~~in ~~Securities~~investing activities of $0 and $0 for the three months ended March 31, 2016 and 2015, respectively.

~~None~~We had net cash provided (used in) by financing activities of $0 and $0 for the three months ended March 31, 2016 and 2015, respectively.

~~Item 4~~We will have to raise funds to pay for our expenses. ~~Mine~~We ~~Safety~~may ~~Disclosures~~have to borrow money from shareholders or issue debt or equity or enter into a strategic arrangement with a third party. There can be no assurance that additional capital will be available to us. We currently have no arrangements or understandings with any person to obtain funds through bank loans, lines of credit or any other sources. Since we have no such arrangements or plans currently in effect, our inability to raise funds for our operations will have a severe negative impact on our ability to remain a viable company.

~~Not applicable.~~Plan of Operation and Funding

~~Item 5~~We expect that working capital requirements will continue to be funded through a combination of our existing funds and further issuances of securities. ~~Other~~Our ~~Information~~working capital requirements are expected to increase in line with the growth of our business.

~~None~~Existing working capital, further advances and debt instruments, and anticipated cash flow are expected to be adequate to fund our operations over the next three months. We have no lines of credit or other bank financing arrangements. Generally, we have financed operations to date through the proceeds of the private placement of equity and debt instruments. In connection with our business plan, management anticipates additional increases in operating expenses and capital expenditures relating to: (i) acquisition of inventory; (ii) developmental expenses associated with a start-up business; and (iii) marketing expenses. We intend to finance these expenses with further issuances of securities, and debt issuances. Thereafter, we expect we will need to raise additional capital and generate revenues to meet long-term operating requirements. Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders. Further, such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict our business operations. We will have to raise additional funds in the next twelve months in order to sustain and expand our operations. We currently do not have a specific plan of how we will obtain such funding; however, we anticipate that additional funding will be in the form of equity financing from the sale of our common stock. We have and will continue to seek to obtain short-term loans from our directors, although no future arrangement for additional loans has been made. We do not have any agreements with our directors concerning these loans. We do not have any arrangements in place for any future equity financing.

1415

~~Item 6.~~Going ~~Exhibits~~Concern

Exhibit No.		Description
31.1		Certification by the Principal Executive Officer of Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Rule 13a-14(a) or Rule 15d-14(a)).
31.2		Certification by the Principal Financial Officer of Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Rule 13a-14(a) or Rule 15d-14(a)).
32.1		Certification by the Principal Executive Officer pursuant to 18 U.S.C. 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2		Certification by the Principal Financial Officer pursuant to 18 U.S.C. 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS		XBRL Instance Document
101.SCH		XBRL Taxonomy Extension Schema Document
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		XBRL Taxonomy Extension Label Linkbase Document
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

The accompanying unaudited financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company had revenue of $0 and net losses of $7,307 for the three months ended March 31, 2016 compared to revenue of $0 and net losses of $560 for the three months ended March 31, 2015. The Company had working capital deficiency, stockholders' deficit, and accumulated deficit of $24,277, $24,277 and $62,877, respectively, at March 31, 2016, and used cash in operations of $84 for the three months ended March 31, 2016. These factors raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time. The Company is highly dependent on its ability to continue to obtain investment capital from future funding opportunities to fund the current and planned operating levels. The unaudited financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company's continuation as a going concern is dependent upon its ability to bring in income generating activities and its ability to continue receiving investment capital from future funding opportunities. No assurance can be given that the Company will be successful in these efforts.

15Off Balance Sheet Arrangements

~~SIGNATURES~~We currently have no off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

~~Pursuant to~~Critical ~~the~~Accounting ~~requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.~~Policies

	Merecot Corp.
Dated: November 20, 2015	By:	/s/ Andrew Stepansky
		Andrew Stepansky
		Chief Executive Officer and Chief Financial Officer

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Such estimates and assumptions affect the reported amounts of revenues and expenses during the reporting period. We base our estimates on historical experiences and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ materially from these estimates under different assumptions and conditions. We continue to monitor significant estimates made during the preparation of our financial statements. On an ongoing basis, we evaluate estimates and assumptions based upon historical experience and various other factors and circumstances. We believe our estimates and assumptions are reasonable in the circumstances; however, actual results may differ from these estimates under different future conditions.

16See Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" and Note 2, "Summary of Significant Accounting Policies" in our audited financial statements for the year ended December 31, 2015, included in our Annual Report on Form 10-K as filed on March 30, 2016, for a discussion of our critical accounting policies and estimates.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

A smaller reporting company, as defined by Item 10 of Regulation S-K, is not required to provide the information required by this item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Securities and Exchange Commission defines the term "disclosure controls and procedures" to mean a company's controls and other procedures of an issuer that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to the issuer's management, including its chief executive and chief financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company maintains such a system of controls and procedures in an effort to ensure that all information which it is required to disclose in the reports it files under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified under the SEC's rules and forms and that information required to be disclosed is accumulated and communicated to the chief executive and interim chief financial officer to allow timely decisions regarding disclosure.

As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Company's disclosure controls and procedures are not effective as of such date. The Chief Executive Officer and Chief Financial Officer have determined that the Company continues to have the following deficiencies which represent a material weakness:

	1.	The Company intends to appoint additional independent directors;

	2.	Lack of in-house personnel with the technical knowledge to identify and address some of the reporting issues surrounding certain complex or non-routine transactions. With material, complex and non-routine transactions, management has and will continue to seek guidance from third-party experts and/or consultants to gain a thorough understanding of these transactions;

	3.	Insufficient personnel resources within the accounting function to segregate the duties over financial transaction processing and reporting;

	4.	Insufficient written policies and procedures over accounting transaction processing and period end financial disclosure and reporting processes.

To remediate our internal control weaknesses, management intends to implement the following measures:

	●	The Company will add sufficient number of independent directors to the board and appoint additional member(s) to the Audit Committee.

	●	The Company will add sufficient accounting personnel to properly segregate duties and to effect a timely, accurate preparation of the financial statements.

	●	The Company will hire staff technically proficient at applying U.S. GAAP to financial transactions and reporting.

	●	Upon the hiring of additional accounting personnel, the Company will develop and maintain adequate written accounting policies and procedures.

The additional hiring is contingent upon The Company's efforts to obtain additional funding through equity or debt and the results of its operations. Management expects to secure funds in the coming fiscal year but provides no assurances that it will be able to do so.

Changes in Internal Control Over Financial Reporting

Except as set forth above, due to the new business plan, we are in the process of finalizing our controls over the new business process.

Limitations on the Effectiveness of Controls

The Company's management, including the CEO and CFO, does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all error and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system's objectives will be met. Further, the design of the control system must reflect that there are resource constraints and that the benefits must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

The Company has been threatened with legal action with a vendor for $2,000. The Company has not completed the transaction as it disputes the quality of services provided by the vendor and cancelled the contract with the vendor. The Company will contest the charge accordingly. Management has determined that the eventual outcome will not have significant effect on the Company's financial statements.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

We did not issue unregistered securities during the quarter ending March 31, 2016.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits

See the Exhibit Index following the signature page of this Registration Statement, which Exhibit Index is incorporated herein by reference.

Number		Description

3.1		Articles of Incorporation (incorporated by reference to our Registration Statement on Form S-1, filed on February 26, 2014)
3.2		Certificate of Amendment (incorporated by reference to our Current Report on Form 8-K, filed on January 19, 2016)
4.2		Bylaws (incorporated by reference to our Registration Statement on Form S-1, filed on February 26, 2014)
31.1 (1)		Certification of Principal Executive Officer of Medresponse Corp. required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2 (1)		Certification of Principal Accounting Officer of Medresponse Corp. required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1 (1)		Certification of Principal Executive Officer of Medresponse Corp. pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 Of 18 U.S.C. 63
32.2 (1)		Certification of Principal Accounting Officer of Medresponse Corp. pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 Of 18 U.S.C. 63
101.INS		XBRL Taxonomy Extension Instance Document
101.SCH		XBRL Taxonomy Extension Schema Document
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		XBRL Taxonomy Extension Label Linkbase Document
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

___________

(1) Filed herewith

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Medresponse Corp.

Dated: May 11, 2016	By:	/s/ Andrew Stepansky
		Andrew Stepansky
		Chief Executive Officer and Chief Financial Officer

Filing Compare · MEDRESPONSE CORP.